Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2006
Dendritic cell-based tumor vaccines and antigen presentation attenuatorsKevin Evel-Kabler, Si-Yi ChenCurrent Opinion in Molecular Therapeutics|March 2, 2006
Inhibition of antigen-presentation attenuators to augment vaccinesKevin Evel-Kabler, Si-Yi ChenNature Biotechnology|November 24, 2004
Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunityLei Shen, Kevin Evel-Kabler, Randy Strube, et al.The Journal of Clinical Investigation|December 17, 2005
SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signalingKevin Evel-Kabler, Xiao-Tong Song, Melissa Aldrich, et al.Nature Medicine|March 4, 2008
A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppressionXiao-Tong Song, Kevin Evel-Kabler, Lei Shen, et al.Cancer Research|October 1, 2009
Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cellsBangxing Hong, Wenhong Ren, Xiao-Tong Song, et al.Plos Medicine|December 31, 2005
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cellsXiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, et al.Pageof 1